` TNON (Tenon Medical Inc) vs S&P 500 Comparison - Alpha Spread

TNON
vs
S&P 500

Over the past 12 months, TNON has underperformed S&P 500, delivering a return of -37% compared to the S&P 500's +14% growth.

Stocks Performance
TNON vs S&P 500

Loading
TNON
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
TNON vs S&P 500

Loading
TNON
S&P 500
Difference
www.alphaspread.com

Performance By Year
TNON vs S&P 500

Loading
TNON
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Tenon Medical Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Tenon Medical Inc
Glance View

Market Cap
11.9m USD
Industry
Health Care

Tenon Medical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Los Gatos, California and currently employs 10 full-time employees. The company went IPO on 2022-04-27. Tenon Medical, Inc. is a medical device company. The firm has developed a proprietary surgical implant system, The CATAMARAN SIJ Fusion System (The CATAMARAN System), which is designed to fuse one or both sacroiliac joints (SI-Joint) to treat SI-Joint dysfunction that often causes severe lower back pain. The CATAMARAN System offers a new surgical solution that places a single implant directly into the SI joint, bridging the sacrum and ilium with a posterior inferior surgical approach. The CATAMARAN System includes instruments and implants designed to prepare and fixate the SI-Joint for fusion. The CATAMARAN System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The company also has developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.

TNON Intrinsic Value
1.37 USD
Undervaluation 20%
Intrinsic Value
Price
Back to Top